Combination Chemotherapy Consisting of Gemcitabine And Topotecan in Treating Patients With Refractory or Recurrent Ovarian or Fallopian Tube Cancer - Contacts and Locations

Combination Chemotherapy Consisting of Gemcitabine And Topotecan in Treating Patients With Refractory or Recurrent Ovarian or Fallopian Tube Cancer

This study has been completed.

Study NCT00003382. Last updated on July 23, 2008. Information provided by National Cancer Institute (NCI)

Please refer to this study by its ClinicalTrials.gov identifier: NCT00003382

Locations


United States, California
	Chao Family Comprehensive Cancer Center
	Orange, California, United States, 92868
	Community Hospital of Los Gatos
	Los Gatos, California, United States, 95032
	Women's Cancer Center
	Palo Alto, California, United States, 94304

United States, Illinois
	University of Chicago Cancer Research Center
	Chicago, Illinois, United States, 60637-1470

United States, Iowa
	Holden Comprehensive Cancer Center at The University of Iowa
	Iowa City, Iowa, United States, 52242-1009

United States, Pennsylvania
	University of Pennsylvania Cancer Center
	Philadelphia, Pennsylvania, United States, 19104-4283

Sponsors and Collaborators

Gynecologic Oncology Group

National Cancer Institute (NCI)

Investigators


Study Chair:	Ming-teh D. Chen, MD	Women's Cancer Center - Los Gatos